Saturday, November 2, 2024
HomeTagsAlzheimer’s patients

Alzheimer’s patients

Cognito Therapeutics Announces Gamma-Frequency Sensory Stimulation Decreases Brain Atrophy in Patients with Alzheimer’s Disease at AD/PD 2023

Cognito Therapeutics, announced neuroimaging results evaluating the effects of the company’s non-invasive neuromodulation medical device, which delivers proprietary gamma frequency light and sound stimulation in...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics